Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cervical cancer
At Hospital/Institution:  Presbyterian - St. Luke's Medical Center
Results 1-25 of 66 for your search:
Start Over
Intensity Modulated Radiation Therapy and Cisplatin in Treating Patients with Stage I-IVA Cervical Cancer
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 110808, NCI-2012-02858, NCT01554397
Chemotherapy and Pelvic Radiation Therapy with or without Additional Chemotherapy in Treating Patients with High-Risk Early-Stage Cervical Cancer after Radical Hysterectomy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 0724/GOG-0724, NCI-2011-01973, CDR0000654709, GOG-0724, RTOG-0724, NCT00980954
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Phase: Phase III
Type: Tissue collection/Repository, Treatment
Age: 18 and over
Trial IDs: GOG-0263, NCI-2011-02037, CDR0000670125, NCT01101451
Cisplatin and Radiation Therapy with or without Lymphadenectomy in Treating Patients with Stage IB-IVA Cervical Cancer
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 2010-0952, NCI-2011-02400, NCT01365156
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: ANZGOG-0902/GOG-0274/RTOG-1174, NCI-2011-02978, ANZGOG-0902, CDR0000706698, GOG-0274, RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
Standard Radiation Therapy or Intensity-Modulated Pelvic Radiation Therapy in Treating Patients with Endometrial or Cervical Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 1203, NCI-2012-02001, CDR0000738944, NCT01672892
Surgery or Non-surgical Management in Treating Patients with Intra-abdominal Cancer and Bowel Obstruction
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: S1316, NCI-2014-01497, SWOG-S1316, NCT02270450
Ohio Patient Navigator Research Program in Reducing Disparities in Cancer Treatment in All Populations
Phase: Phase III
Type: Health services research, Screening
Age: 18 and over
Trial IDs: OSU-06100, NCI-2012-00205, 2006C0077, NCT01569672
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CRAB CTC 11-001, NCI-2014-02260, CAR-IST-553, NCI-2013-02243, NCT01941316
ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ME-344-002, NCI-2014-01013, NCT02100007
A Study of VGX-3100 and INO-9012 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 70
Trial IDs: HPV-004, NCI-2015-00497, NCT02172911
T-cell Receptor Gene Therapy Targeting HPV-16 E6 in Treating Patients with Metastatic, Recurrent, or Refractory HPV-Related Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 66
Trial IDs: 15-C-0005, NCI-2014-02319, 1407-1331, 337514, P141607, RD-14-VIII-09, NCT02280811
Vaccine Therapy in Treating Patients with Persistent or Recurrent Cervical Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GOG-0265, NCI-2011-02671, CDR0000691288, NCT01266460
Cisplatin and Radiation Therapy in Treating Patients with HIV and Stage IB-IVA Cervical Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AMC-081, NCI-2013-01314, NCT01590017
Tumor-Infiltrating Lymphocytes and High-Dose Aldesleukin after Combination Chemotherapy in Treating Patients with Metastatic or Locally Advanced Refractory Human Papilloma Virus-Associated Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-C-0116, NCI-2013-01524, 120116, 12C0116-H, 327146, P11943, NCT01585428
Eribulin Mesylate in Treating Patients with Advanced or Recurrent Cervical Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 5C-11-2, NCI-2012-01378, HS-11-00547, NCT01676818
FLT PET/CT in Planning Pelvic Radiation Therapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 201204712, NCI-2013-00956, 04120117, NCT01717391
Cisplatin and Radiation Therapy with or without Triapine in Treating Patients with Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CASE 4812, NCI-2013-00804, NCI 9434, 9434, NCT01835171
Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients with Gynecological Cancer after Undergoing Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Tissue collection/Repository
Age: 18 and over
Trial IDs: MC1267, NCI-2013-00866, NCT01867606
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients with Metastatic, Persistent, or Recurrent Cervical Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-334, NCI-2013-02357, NCT01958112
Nivolumab in Treating Patients with Persistent, Recurrent, or Metastatic Cervical Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NRG-GY002, NCI-2014-02021, PNRG-GY002_A01PAMDREVW01, NCT02257528
Biobehavioral Intervention in Gynecologic Oncology Patients
Phase: Phase II
Type: Supportive care
Age: 21 to 80
Trial IDs: 14-GYN-02-MCC, R25 CA163197, NCT02454036
Start Over